O
OrbiMed’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.7M | Buy |
1,482,300
+50,000
| +3% | +$866K | 0.64% | 39 |
|
|
2025
Q1 | $31.3M | Buy |
+1,432,300
| New | +$31.3M | 0.75% | 37 |
|
|
2024
Q4 | – | Sell |
-1,270,400
| Closed | -$36.6M | – | 115 |
|
|
2024
Q3 | $36.6M | Sell |
1,270,400
-32,400
| -2% | -$934K | 0.67% | 44 |
|
|
2024
Q2 | $50M | Buy |
1,302,800
+5,000
| +0.4% | +$192K | 0.99% | 32 |
|
|
2024
Q1 | $76.3M | Buy |
1,297,800
+375,600
| +41% | +$22.1M | 1.4% | 25 |
|
|
2023
Q4 | $55.2M | Sell |
922,200
-338,300
| -27% | -$20.3M | 1.1% | 32 |
|
|
2023
Q3 | $47.9M | Buy |
1,260,500
+350,300
| +38% | +$13.3M | 1.02% | 35 |
|
|
2023
Q2 | $82.9M | Hold |
910,200
| – | – | 1.5% | 22 |
|
|
2023
Q1 | $60M | Buy |
+910,200
| New | +$60M | 1.18% | 26 |
|
|
2020
Q2 | – | Sell |
-50,485
| Closed | -$1.35M | – | 133 |
|
|
2020
Q1 | $1.35M | Buy |
+50,485
| New | +$1.35M | 0.02% | 125 |
|
|
2019
Q4 | – | Sell |
-623,859
| Closed | -$15M | – | 133 |
|
|
2019
Q3 | $15M | Sell |
623,859
-1,199,841
| -66% | -$28.9M | 0.29% | 70 |
|
|
2019
Q2 | $46.2M | Buy |
1,823,700
+61,400
| +3% | +$1.56M | 0.72% | 42 |
|
|
2019
Q1 | $34.4M | Buy |
1,762,300
+1,435,300
| +439% | +$28M | 0.53% | 51 |
|
|
2018
Q4 | $4.31M | Buy |
+327,000
| New | +$4.31M | 0.08% | 100 |
|